Biblio Discovery — Demo Discovery Service

9 hasil untuk "Mathieu Ferrari"

Menampilkan 1–9 · 0,03 detik · RSS

  1. Artikel Jurnal

    Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis

    Mathieu Ferrari; Shimobi C. Onuoha; Liliane Fossati-Jimack dkk.

    Frontiers in Immunology, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    Biologic drugs, especially anti-TNF, are considered as the gold standard therapy in rheumatoid arthritis. However, non-uniform efficacy, incidence of infections, and high costs are major concerns. Novel tissue-specific agents may overcome the current limitations of systemic administration…

  2. Artikel Jurnal

    Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike

    Leila Mekkaoui; Emma Bentley; Mathieu Ferrari dkk.

    Bio-Protocol, Vol. 11 No. 16 · 2021 · Inggris · DOAJ Scopus

    The use of recombinant lentivirus pseudotyped with the coronavirus Spike protein of SARS-CoV-2 would circumvent the requirement of biosafety-level 3 (BSL-3) containment facilities for the handling of SARS-CoV-2 viruses. Herein, we describe a fast and reliable protocol for the transient production…

  3. Artikel Jurnal

    Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments

    Francesco Nannini; Lenart Senicar; Farhaan Parekh dkk.

    mAbs, Vol. 13 No. 1 · 2021 · Inggris · DOAJ Scopus

    Phage display technology in combination with next-generation sequencing (NGS) currently is a state-of-the-art method for the enrichment and isolation of monoclonal antibodies from diverse libraries. However, the current NGS methods employed for sequencing phage display libraries are limited by the…

  4. Artikel Jurnal

    Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry

    Pedro Horna; Matthew J. Weybright; Mathieu Ferrari dkk.

    Blood Cancer Journal, Vol. 14 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract The diagnosis of leukemic T-cell malignancies is often challenging, due to overlapping features with reactive T-cells and limitations of currently available T-cell clonality assays. Recently developed therapeutic antibodies specific for the mutually exclusive T-cell receptor constant β…

  5. Artikel Jurnal

    Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2

    Julia Taylor; Anna Bulek; Isaac Gannon dkk.

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    SHP1 and SHP2 are SH2 domain-containing proteins which have inhibitory phosphatase activity when recruited to phosphorylated ITIMs and ITSMs on inhibitory immune receptors. Consequently, SHP1 and SHP2 are key proteins in the transmission of inhibitory signals within T cells, constituting an…

  6. Artikel Jurnal Teks lengkap

    CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

    Shaun P Cordoba; Shimobi C. Onuoha; Simon Thomas dkk.

    Nature Medicine · 2021 · Inggris · OpenAlex Scopus

    Chimeric antigen receptor (CAR) T cells targeting CD19 or CD22 have shown remarkable activity in B cell acute lymphoblastic leukemia (B-ALL). The major cause of treatment failure is antigen downregulation or loss. Dual antigen targeting could potentially prevent this, but the clinical safety and…

  7. Artikel Jurnal

    Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

    Simon Thomas; Julia Taylor; Manuel Rodriguez-Justo dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 11 No. 6 · 2023 · Inggris · DOAJ Scopus

    Background We used a proliferating ligand (APRIL) to construct a ligand-based third generation chimeric antigen receptor (CAR) able to target two myeloma antigens, B-cell maturation antigen (BCMA) and transmembrane activator and CAML interactor.Methods The APRIL CAR was evaluated in a Phase 1…

  8. Artikel Jurnal

    Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies

    Mathieu Ferrari; Matteo Righi; Vania Baldan dkk.

    Nature Communications, Vol. 15 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Peripheral T cell lymphomas are typically aggressive with a poor prognosis. Unlike other hematologic malignancies, the lack of target antigens to discriminate healthy from malignant cells limits the efficacy of immunotherapeutic approaches. The T cell receptor expresses one of two highly…